CORDIS
EU research results

CORDIS

English EN

Novel diagnostic bio-assays based on magnetic particles

Project information

Grant agreement ID: 264737

Status

Closed project

  • Start date

    1 February 2011

  • End date

    31 January 2015

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 3 236 392,01

  • EU contribution

    € 3 236 392,01

Coordinated by:

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium

Objective

Nanotechnology-based in-vitro diagnostics is set to solve several important problems in global healthcare. R&D in this field requires collaborations between experts from different scientific disciplines with a strong focus on the integration of bio-, nano- and microtechnologies. However, such personnel is still scarce. This BioMaX training-through-research network responds to the need for skilled personnel able to combine bio-assay knowledge with novel integrated device technologies. The general objective of the BioMaX network is to train the next generation of biomolecular researchers in industry and academia by establishing a pan-European network that aims at improving the career perspectives of young potentials and putting Europe at the R&D frontline in integrated diagnostics. To realize this objective a top-level consortium, consisting of 6 academic and 4 industrial partners, will establish an innovative S&T and training program. The network will investigate novel diagnostic bio-assay technologies for proteins and nucleic acids based on magnetic particles (MPs), with demonstration of breakthroughs in analytical performance and device integration. The program is built on three scientific pillars: molecular bio-assay strategies, biomolecular kinetics, and integrated bio-assay devices. The training and exchange program addresses both academic expertise and complementary skills tailored to the individual needs of the fellows. Fellows will be offered local training at doctoral schools and network-wide training through summer schools, workshops, conferences, and secondments. With the creation of this leadership network on novel biological assays, BioMaX assists the EC in reaching their objectives in the area of mobility and training of researchers and the realization of a powerful European Research Area with joint research priorities and a world class infrastructure capable of attracting a critical mass of human and financial resources.

Coordinator

KATHOLIEKE UNIVERSITEIT LEUVEN

Address

Oude Markt 13
3000 Leuven

Belgium

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 838 918,40

Administrative Contact

Tine Heylen (Ms.)

Participants (6)

TECHNISCHE UNIVERSITEIT EINDHOVEN

Netherlands

EU Contribution

€ 519 487,70

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

Switzerland

EU Contribution

€ 478 424,80

UNIVERSITE PIERRE ET MARIE CURIE - PARIS 6

France

EU Contribution

€ 246 392,31

UNIVERSIDAD AUTONOMA DE BARCELONA

Spain

EU Contribution

€ 453 459,20

UPPSALA UNIVERSITET

Sweden

EU Contribution

€ 493 697,20

PHILIPS ELECTRONICS NEDERLAND BV

Netherlands

EU Contribution

€ 206 012,40

Project information

Grant agreement ID: 264737

Status

Closed project

  • Start date

    1 February 2011

  • End date

    31 January 2015

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 3 236 392,01

  • EU contribution

    € 3 236 392,01

Coordinated by:

KATHOLIEKE UNIVERSITEIT LEUVEN

Belgium